1. RESILIENT part 1: a phase 2 dose‐exploration and dose‐expansion study of second‐line liposomal irinotecan in adults with small cell lung cancer. Issue 9 (23rd February 2022) Authors: Paz‐Ares, Luis; Spigel, David R.; Chen, Yuanbin; Jove, Maria; Juan‐Vidal, Oscar; Rich, Patricia; Hayes, Theresa; Calderón, Vanesa Gutiérrez; Caro, Reyes Bernabe; Navarro, Alejandro; Dowlati, Afshin; Zhang, Bin; Moore, Yan; Yao, Xiaopan; Kokhreidze, Jaba; Ponce, Santiago; Bunn, Paul A. Journal: Cancer Issue: Volume 128:Issue 9(2022) Page Start: 1801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗